Clinical Chemistry, Malmö
851 – 860 of 1292
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Identification of the MMRN1 binding region within the C2 domain of human factor V
(
- Contribution to journal › Article
-
Mark
A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia
(
- Contribution to journal › Article
-
Mark
Enhanced rate of cleavage at Arg306 and Arg506 in coagulation factor Va by Gla domain-mutated human activated protein C.
(
- Contribution to journal › Article
-
Mark
Integrated selective enrichment target - a microtechnology platform for matrix-assisted laser desorption/ionization-mass spectrometry applied on protein biomarkers in prostate diseases
(
- Contribution to journal › Article
-
Mark
Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
(
- Contribution to journal › Article
-
Mark
KSHV complement control protein mimics human molecular mechanisms for inhibition of the complement system.
(
- Contribution to journal › Article
-
Mark
Gene deletion of cystatin C aggravates brain damage following focal ischemia but mitigates the neuronal injury after global ischemia in the mouse.
(
- Contribution to journal › Article
-
Mark
Differential response of human cardiac fibroblasts to angiotensin I and angiotensin II
(
- Contribution to journal › Article
-
Mark
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma
(
- Contribution to journal › Article
-
Mark
Lead time associated with screening for prostate cancer
(
- Contribution to journal › Article